Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1996 4
1997 1
1999 2
2000 1
2001 3
2002 5
2003 3
2004 2
2005 10
2006 7
2007 12
2008 3
2009 6
2010 6
2011 7
2012 10
2013 12
2014 7
2015 9
2016 5
2017 4
2018 4
2019 6
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Results by year
Filters applied: . Clear all
Page 1
Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.
Söderholm J, Yilmaz A, Svenningsson A, Büsch K, Wejstål R, Brolund A, Kövamees J, Sällberg M, Lagging M, Gisslén M. Söderholm J, et al. J Neurol. 2019 Sep;266(9):2208-2215. doi: 10.1007/s00415-019-09397-8. Epub 2019 May 31. J Neurol. 2019. PMID: 31152298 Free PMC article. Clinical Trial.
BACKGROUND: Multiple sclerosis (MS) is an immune-mediated neurological disease that causes demyelination. The etiology is unknown, but patients with a previous viral infection, such as Epstein-Barr virus, have been shown to be at a higher risk of developing MS. ... …
BACKGROUND: Multiple sclerosis (MS) is an immune-mediated neurological disease that causes demyelination. The etiology is unkn …
Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Tagawa A, Ogawa T, Tetsuka S, Otsuka M, Hashimoto R, Kato H, Ando K, Tanabe H. Tagawa A, et al. Mult Scler Relat Disord. 2016 Sep;9:155-7. doi: 10.1016/j.msard.2016.08.003. Epub 2016 Aug 5. Mult Scler Relat Disord. 2016. PMID: 27645365
We here report a case involving a 38-year-old female with relapsing and remitting multiple sclerosis who developed reactivation of hepatitis C virus (HCV) during administration of fingolimod for 16 months. She had been previously treated for chronic …
We here report a case involving a 38-year-old female with relapsing and remitting multiple sclerosis who developed reactivatio …
Alemtuzumab.
[No authors listed] [No authors listed] 2020 Apr 14. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012–. PMID: 31643537 Free Books & Documents. Review.
Alemtuzumab is a recombinant human monoclonal antibody to human CD52 which is used in the therapy of chronic lymphocytic leukemia, in induction regimens for solid organ transplantation and for resistant forms of relapsing multiple sclerosis. Alemtuzumab has not been …
Alemtuzumab is a recombinant human monoclonal antibody to human CD52 which is used in the therapy of chronic lymphocytic leukemia, in induct …
Interferon Beta: From Molecular Level to Therapeutic Effects.
Haji Abdolvahab M, Mofrad MR, Schellekens H. Haji Abdolvahab M, et al. Int Rev Cell Mol Biol. 2016;326:343-72. doi: 10.1016/bs.ircmb.2016.06.001. Epub 2016 Jul 20. Int Rev Cell Mol Biol. 2016. PMID: 27572132 Review.
The biological activities underpin the mechanisms by which the protein is used to treat various diseases such as hepatitis C infection and multiple sclerosis. ...
The biological activities underpin the mechanisms by which the protein is used to treat various diseases such as hepatitis C i …
Multiple Sclerosis Like Condition in a Patient of Hepatitis C after Treatment with Interferon Alpha: A Case Report.
Fazil PA, Ali SM, Zaboli M, Shah SR. Fazil PA, et al. J Clin Diagn Res. 2015 May;9(5):OD14-5. doi: 10.7860/JCDR/2015/12588.5962. Epub 2015 May 1. J Clin Diagn Res. 2015. PMID: 26155513 Free PMC article.
Hepatitis C virus affects millions of people around the world. The primary therapy comprises of interferon alpha and ribavarin. ...Research suggests that early treatment of Multiple Sclerosis (MS) is beneficial in the long run with a better prognosis a
Hepatitis C virus affects millions of people around the world. The primary therapy comprises of interferon alpha and ribavarin
Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?
Mader EC Jr, Richeh W, Ochoa JM, Sullivan LL, Gutierrez AN, Lovera JF. Mader EC Jr, et al. J Neurol Sci. 2015 Feb 15;349(1-2):239-42. doi: 10.1016/j.jns.2014.12.034. Epub 2015 Jan 3. J Neurol Sci. 2015. PMID: 25575859
Hepatitis C virus (HCV) infection has been implicated in triggering acute disseminated encephalomyelitis but not tumefactive multiple sclerosis. ...Tumefactive multiple sclerosis was diagnosed based on the absence of encephalopathic signs
Hepatitis C virus (HCV) infection has been implicated in triggering acute disseminated encephalomyelitis but not tumefactive
Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes.
Fortunato G, Calcagno G, Bresciamorra V, Salvatore E, Filla A, Capone S, Liguori R, Borelli S, Gentile I, Borrelli F, Borgia G, Sacchetti L. Fortunato G, et al. J Interferon Cytokine Res. 2008 Mar;28(3):141-52. doi: 10.1089/jir.2007.0049. J Interferon Cytokine Res. 2008. PMID: 18338947
We have studied 35 single nucleotide polymorphisms (SNPs) in the interferon (IFN) pathway to determine their contribution to multiple sclerosis (MS) and hepatitis C virus (HCV) infection. A total of 182 patients with MS, 103 patients with chronic he
We have studied 35 single nucleotide polymorphisms (SNPs) in the interferon (IFN) pathway to determine their contribution to multiple
Hepatitis C and D, retroviruses and autoimmune manifestations.
Obermayer-Straub P, Manns MP. Obermayer-Straub P, et al. J Autoimmun. 2001 May;16(3):275-85. doi: 10.1006/jaut.2000.0488. J Autoimmun. 2001. PMID: 11334493 Review.
Anti-HIAP and anti-HIV p24 autoantibodies are seen in systemic lupus erythematosus, primary biliary cirrhosis and multiple sclerosis. Multiple sclerosis was even associated with a new human retrovirus called multiple sclerosis associated …
Anti-HIAP and anti-HIV p24 autoantibodies are seen in systemic lupus erythematosus, primary biliary cirrhosis and multiple scleros
Dual benefit from intramuscular interferon-beta treatment in a patient with multiple sclerosis and chronic hepatitis-C virus infection.
Tan FU, Cetinkaya H, Erden E, Ulkatan S, Aydin N. Tan FU, et al. Hepatogastroenterology. 2002 Nov-Dec;49(48):1686-7. Hepatogastroenterology. 2002. PMID: 12397766
However we would like to present a patient with multiple sclerosis and chronic hepatitis C virus infection who obtained dual benefit from intramuscular interferon-beta therapy. ...Liver biopsy revealed chronic persistent hepatitis. Considering t …
However we would like to present a patient with multiple sclerosis and chronic hepatitis C virus infection who o …
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED. Salk A, et al. Ann Pharmacother. 2013 Apr;47(4):537-42. doi: 10.1345/aph.1R526. Epub 2013 Mar 27. Ann Pharmacother. 2013. PMID: 23535814
OBJECTIVE: To better characterize the association between type I interferons and ischemic colitis (IC) in patients with the hepatitis C virus (HCV) and multiple sclerosis (MS), by analyzing reports submitted to the Food and Drug Administration (FDA) Ad …
OBJECTIVE: To better characterize the association between type I interferons and ischemic colitis (IC) in patients with the hepatitis
130 results
Jump to page
Feedback